Clinical Aspects: Grading, Staging, and Paraneoplastic Syndromes
Start with the big picture
Grading evaluates features such as differentiation, nuclear atypia, mitotic activity, and necrosis; lower-grade tumors are generally more differentiated and associated with a better prognosis. Staging assesses anatomic spread and is generally more important for prognosis. The TNM framework describes the primary tumor, regional lymph nodes, and distant metastasis, with stages grouped from 0 to IV. Paraneoplastic syndromes result from mechanisms such as ectopic hormone or cytokine production, immune cross-reactivity, and hypercoagulability. Examples include endocrine disturbances, neuromuscular effects, skin changes, and thrombotic complications. Some syndromes can appear before a tumor is identified, making recognition of the pattern clinically relevant.
What you'll learn
- Distinguish histologic grading from anatomic staging.
- Identify the features used to assess tumor grade.
- Describe the T, N, and M components of TNM staging.
- Recognize common mechanisms and clinical patterns of paraneoplastic syndromes.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.